Four Rare Disease Medicines Witness Price Drop Amidst Domestic Production
Union Health Ministry officials said on Friday that because Indian pharmaceutical businesses are now developing medicines for four rare diseases instead of relying on pricey import formulations, these medicines are now available at substantially lower costs. The price cuts come as the government prioritizes work on 13 uncommon illnesses, including sickle cell anaemia. Drugs for … Read more